Gene Therapy Using Recombinant Adeno-Associated Virus for Leber Congenital Amaurosis Induced by RPE65 Mutation

Iman Owliaee, Ali Teimoori, Mohammad Shoushtari, Ali Shojaeian

Open source

DOI
10.2147/opth.s593854
Published
2026-04
Container
Clinical Ophthalmology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/opth.s593854,
  title = {Gene Therapy Using Recombinant Adeno-Associated Virus for Leber Congenital Amaurosis Induced by RPE65 Mutation},
  author = {Iman Owliaee and Ali Teimoori and Mohammad Shoushtari and Ali Shojaeian},
  year = {2026},
  journal = {Clinical Ophthalmology},
  doi = {10.2147/opth.s593854},
  url = {https://doi.org/10.2147/opth.s593854}
}

RIS

TY  - JOUR
TI  - Gene Therapy Using Recombinant Adeno-Associated Virus for Leber Congenital Amaurosis Induced by RPE65 Mutation
AU  - Iman Owliaee
AU  - Ali Teimoori
AU  - Mohammad Shoushtari
AU  - Ali Shojaeian
PY  - 2026
JO  - Clinical Ophthalmology
DO  - 10.2147/opth.s593854
UR  - https://doi.org/10.2147/opth.s593854
ER  - 

APA

Owliaee, I., Teimoori, A., Shoushtari, M., & Shojaeian, A. (2026). Gene Therapy Using Recombinant Adeno-Associated Virus for Leber Congenital Amaurosis Induced by RPE65 Mutation. Clinical Ophthalmology. https://doi.org/10.2147/opth.s593854

Source records